CoQ10 and psilocybin for rheumatism: what does the research say and could a combination be beneficial?

In conditions such as (juvenile) rheumatism, both biochemical and mental factors are increasingly being considered. We will first explain what current research says about CoQ10 and psilocybin separately, and then we will examine whether a combination, for example CoQ10 in preparation for a guided psilocybin session, may possibly have an additional effect on rheumatism

What do we know about CoQ10 in (juvenile) rheumatism?

Coenzyme Q10, often abbreviated as CoQ10, is a substance naturally occurring in the body that plays a central role in cellular energy production. It is found in the mitochondria and helps convert food into energy. Additionally, it acts as an antioxidant, which means it can help reduce oxidative stress.

In rheumatic diseases, including juvenile idiopathic arthritis (JIA), inflammatory processes and oxidative stress play an important role. In a In a recent clinical study in children with JIA, CoQ10 was added to the existing treatment.. The results showed that:

1. Disease activity decreased significantly after a few months of use.

2. Inflammatory markers such as TNF-α decreased.

3. Oxidative stress decreased, measured via MDA, among other methods.

4. Antioxidants such as glutathione actually increased.

After three months, the group using CoQ10 showed a clear improvement. The severity of juvenile rheumatoid arthritis decreased by more than half, while the JADAS-10 score dropped by 53 percent. Consequently, disease activity shifted from a high level to a moderate level.

For the participants, this likely meant a lower risk of joint damage, less pain, and reduced inflammatory activity in the joints. It also indicates a better quality of life and a situation in which the condition came under better control.

In summary, current research indicates that CoQ10 may play a supportive role in reducing inflammatory load and improving cellular energy metabolism.

What does psilocybin do on a biochemical level?

Psilocybin, the active ingredient in magic truffles, is primarily known for its mental and consciousness-altering effects. Yet, something happens on biological level much more.

Various studies and analyses show that psilocybin:

1. The activity of the serotonin system is influenced via the 5-HT2A receptor.

2. Can modulate inflammatory processes, among other things via inhibition of NF-κB and influence on cytokines such as TNF-α and IL-6.

3. Neuroplasticity stimulates, among other things, via BDNF and mTOR pathways.

4. Potentially reduces oxidative stress indirectly via the regulation of cellular processes.

In addition, there is a psychological component that should not be underestimated. Chronic stress and emotional strain often play a role in the worsening of physical complaints. Psilocybin sessions can lead to insights, relaxation, and a different way of dealing with pain and tension.

There are even case reports in which a temporary or long-term reduction of rheumatic symptoms was observed after the use of psilocybin, although this remains anecdotal and not sufficient as evidence.

Can a combination of CoQ10 and psilocybin work synergistically?

When we compare the mechanisms, an interesting hypothesis emerges.

CoQ10 works primarily on the physical level:

1. It supports mitochondria and energy production.

2. It reduces oxidative stress.

3. It can reduce inflammatory markers.

Psilocybin has a broader effect:

1. It influences the immune system via serotonergic pathways.

2. It can modulate inflammatory processes via mechanisms of action other than CoQ10.

3. It influences stress, perception, and mental patterns.

This is where the idea of possible synergy arises.

Why would preparation with CoQ10 be interesting?

When someone enters a psilocybin session, the physical state of the body plays an important role. A body with less oxidative stress and a better functioning energy system can theoretically:

1. Coping better with the intensity of the experience.

2. Experience less physiological stress during the session.

3. Potentially have a more favorable inflammatory profile prior to the session.

In that sense, CoQ10 could function as a form of biochemical preparation.

Possible overlap and reinforcement

The hypothesis is that both interventions can complement each other:

1. Double anti-inflammatory
   CoQ10 via antioxidative and mitochondrial pathways, psilocybin via serotonergic and immunological pathways.

2. Oxidative stress + regulation
   CoQ10 reduces direct oxidative damage, while psilocybin may indirectly affect antioxidant systems.

3. Body and mind at the same time
   CoQ10 supports the body, and psilocybin can contribute to mental relaxation and processing, which in turn can indirectly influence physical processes.

4. Stress reduction as a key mechanism
   Chronic stress is a known factor in the exacerbation of inflammatory processes. Psilocybin may play a role here, while CoQ10 helps limit the physical consequences of stress.

What are the limitations of this hypothesis?

It is important not to get ahead of ourselves here.

1. There is, after all, no direct research into the combination of CoQ10 and psilocybin for rheumatism.

2. Most psilocybin studies have been conducted on adults and not on children, whereas the latest CoQ10 study was conducted on children.

3. Effects on inflammation have been demonstrated, but not yet specifically in rheumatic conditions in controlled studies.

4. The interaction with regular medication has been insufficiently investigated.

In other words: the reasoning is biologically plausible, but not yet proven.

Conclusion

The current research shows that both CoQ10 and psilocybin can influence processes that play a role in rheumatism, such as inflammation and oxidative stress. CoQ10 acts primarily at the physical and mitochondrial level, while psilocybin can exert its effect via both biochemical and mental pathways.

From that combination arises an interesting hypothesis: the use of CoQ10 in preparation for a guided psilocybin session could potentially create a more favorable starting position, resulting in a greater overall impact on the system than when both are used separately.

At the same time, it must be emphasized that this has not yet been scientifically proven. Further studies are needed to determine whether this combination actually works synergistically, what the optimal dosage would be, and for which target groups this may be relevant.

Until then, this can primarily be seen as a promising direction for future research, incorporating both the body and consciousness into the understanding of complex conditions such as rheumatism.